TELUMIO Trademark

Trademark Overview


On Friday, February 2, 2018, a trademark application was filed for TELUMIO with the United States Patent and Trademark Office. The USPTO has given the TELUMIO trademark a serial number of 87781724. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2019. This trademark is owned by Celltrion, Inc.. The TELUMIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparation...
telumio

General Information


Serial Number87781724
Word MarkTELUMIO
Filing DateFriday, February 2, 2018
Status700 - REGISTERED
Status DateTuesday, May 21, 2019
Registration Number5754510
Registration DateTuesday, May 21, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelltrion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Party NameCelltrion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressINCHEON
KR

Trademark Events


Event DateEvent Description
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 2, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 6, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 6, 2018LETTER OF SUSPENSION E-MAILED
Thursday, September 6, 2018SUSPENSION LETTER WRITTEN
Friday, August 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 29, 2018ASSIGNED TO LIE
Monday, August 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 16, 2018NON-FINAL ACTION E-MAILED
Wednesday, May 16, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 6, 2018NEW APPLICATION ENTERED IN TRAM